Beta Bionics (BBNX) Cash from Operations (2024 - 2026)

Beta Bionics has disclosed Cash from Operations across 3 years of filings, most recently posting 23832000.0 for Q1 2026.

• Cash from Operations for Q1 2026 came in at 23832000.0, down 19.31% year-over-year; the trailing twelve-month figure through Mar 2026 was 54782000.0 (up 2.36% YoY), and the FY2025 annual result was 50925000.0, down 5.49% from the prior year.
• Cash from Operations came in at 23832000.0 for Q1 2026 at Beta Bionics, down from 8627000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 8627000.0 in Q4 2025 to a low of 23832000.0 in Q1 2026.
• The 3-year median for Cash from Operations is 12237000.0 (2024), against an average of 13670000.0.
• Peak annual rise in Cash from Operations reached 39.58% in 2025, while the deepest fall reached 64.48% in 2025.
• Beta Bionics' Cash from Operations stood at 14279000.0 in 2024, then jumped by 39.58% to 8627000.0 in 2025, then plunged by 176.25% to 23832000.0 in 2026.
• The last three Cash from Operations figures came in at 23832000.0 (Q1 2026), 8627000.0 (Q4 2025), and 8729000.0 (Q3 2025), per Business Quant data.